Publication Name	World Journal of Clinical Cases
Manuscript ID	78693
Country	China

Received	2022-07-21 11:00
Peer-Review Started	2022-07-21 11:02
First Decision by Editorial Office Director	2022-08-04 07:41
Return for Revision	2022-08-04 07:41
Revised	2022-08-16 15:38
Publication Fee Transferred
Second Decision by Editor	2022-09-20 03:25
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2022-09-21 00:29
Articles in Press	2022-09-21 00:29
Edit the Manuscript by Language Editor	2022-09-18 09:54
Typeset the Manuscript	2022-10-17 13:42
Publish the Manuscript Online	2022-10-27 04:55

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Infectious Diseases
Manuscript Type	Observational Study
Article Title	Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China
Manuscript Source	Unsolicited Manuscript
All Author List	Sheng-Wei Cai, Jin-Yan Chen, Rong Wan, De-Jian Pan, Wei-Lin Yang and Ren-Gui Zhou
ORCID	Author(s) ORCID Number Rong Wan http://orcid.org/0000-0002-5575-7292 Wei-Lin Yang http://orcid.org/0000-0002-9564-6132
Funding Agency and Grant Number
Corresponding Author	Rong Wan, BHMS, Chief Nurse, Department of Quality Control, The 904th Hospital of Joint Logistic Support Force, No. 101 Xingyuan North Road, Wuxi 214044, Jiangsu Province, China. yings2007@21cn.com
Key Words	SARS-CoV-2; Vaccine; Cancer; COVID-19; Immunotherapy
Core Tip	Newer strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have made the ongoing global coronavirus disease 2019 pandemic critical. Patients with cancer form a high-risk group, as those with active cancer or those treated with immunosuppressive therapies are more likely to be infected by SARS-CoV-2. Our study indicated the efficacy and safety of two-dose SARS-CoV-2 vaccines in cancer subjects.
Publish Date	2022-10-27 04:55
Citation	Cai SW, Chen JY, Wan R, Pan DJ, Yang WL, Zhou RG. Efficacy and safety profile of two-dose SARS-CoV-2 vaccines in cancer patients: An observational study in China. World J Clin Cases 2022; 10(31): 11411-11418
URL	https://www.wjgnet.com/2307-8960/full/v10/i31/11411.htm
DOI	https://dx.doi.org/10.12998/wjcc.v10.i31.11411

Full Article (PDF)	WJCC-10-11411.pdf
Full Article (Word)	WJCC-10-11411.docx
Manuscript File	78693_Auto_Edited-JJW-WangTQ-JLW.docx
Answering Reviewers	78693-Answering reviewers.pdf
Audio Core Tip	78693-Audio core tip.mp3
Biostatistics Review Certificate	78693-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	78693-Conflict-of-interest statement.pdf
Copyright License Agreement	78693-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	78693-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	78693-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	78693-Language certificate.pdf
Peer-review Report	78693-Peer-review(s).pdf
Scientific Misconduct Check	78693-Bing-Wang JJ-2.png
Scientific Editor Work List	78693-Scientific editor work list.pdf
CrossCheck Report	78693-CrossCheck report.pdf